|
1
|
Zaravinos A, Radojicic J, Lambrou GI, et
al: Expression of miRNAs involved in angiogenesis, tumor cell
proliferation, tumor suppressor inhibition, epithelial-mesenchymal
transition and activation of metastasis in bladder cancer. J Urol.
188:615–623. 2012. View Article : Google Scholar
|
|
2
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zamore PD and Haley B: Ribo-gnome: the big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
White NM, Fatoohi E, Metias M, Jung K,
Stephan C and Yousef GM: Metastamirs: a stepping stone towards
improved cancer management. Nat Rev Clin Oncol. 8:75–84. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
View Article : Google Scholar
|
|
11
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family.
Cell. 120:635–647. 2005. View Article : Google Scholar
|
|
12
|
Liang S, He L, Zhao X, et al: MicroRNA
let-7f inhibits tumor invasion and metastasis by targeting MYH9 in
human gastric cancer. PLoS One. 6:e184092011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sampson VB, Rong NH, Han J, et al:
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth
in Burkitt lymphoma cells. Cancer Res. 67:9762–9770. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gabriely G, Yi M, Narayan RS, et al: Human
glioma growth is controlled by microRNA-10b. Cancer Res.
71:3563–3572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian Y, Luo A, Cai Y, et al: MicroRNA-10b
promotes migration and invasion through KLF4 in human esophageal
cancer cell lines. J Biol Chem. 285:7986–7994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li H, Wang J, Xiao W, et al: Epigenetic
inactivation of KLF4 is associated with urothelial cancer
progression and early recurrence. J Urol. 191:493–501. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yori JL, Seachrist DD, Johnson E, et al:
Krüppel-like factor 4 inhibits tumorigenic progression and
metastasis in a mouse model of breast cancer. Neoplasia.
13:601–610. 2011.
|
|
18
|
Lin ZS, Chu HC, Yen YC, Lewis BC and Chen
YW: Krüppel-like factor 4, a tumor suppressor in hepatocellular
carcinoma cells reverts epithelial mesenchymal transition by
suppressing slug expression. PLoS One. 7:e435932012.
|
|
19
|
Liu YN, Abou-Kheir W, Yin JJ, et al:
Critical and reciprocal regulation of KLF4 and SLUG in transforming
growth factor β-initiated prostate cancer epithelial-mesenchymal
transition. Mol Cell Biol. 32:941–953. 2012.PubMed/NCBI
|
|
20
|
Yori JL, Johnson E, Zhou G, Jain MK and
Keri RA: Krüppel-like factor 4 inhibits epithelial-to-mesenchymal
transition through regulation of E-cadherin gene expression. J Biol
Chem. 285:16854–16863. 2010.
|
|
21
|
Myers C, Charboneau A, Cheung I, Hanks D
and Boudreau N: Sustained expression of homeobox D10 inhibits
angiogenesis. Am J Pathol. 161:2099–2109. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iorio MV and Croce CM: Causes and
consequences of microRNA dysregulation. Cancer J. 18:215–222. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun L, Yan W, Wang Y, et al: MicroRNA-10b
induces glioma cell invasion by modulating MMP-14 and uPAR
expression via HOXD10. Brain Res. 1389:9–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
miR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–1560.
2012.PubMed/NCBI
|
|
25
|
Nakata K, Ohuchida K, Mizumoto K, et al:
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its
invasiveness, and correlates with a poor prognosis. Surgery.
150:916–922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li G, Wu Z, Peng Y, et al: MicroRNA-10b
induced by Epstein-Barr virus-encoded latent membrane protein-1
promotes the metastasis of human nasopharyngeal carcinoma cells.
Cancer Lett. 299:29–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chai G, Liu N, Ma J, et al: MicroRNA-10b
regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci.
101:1997–2004. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nishida N, Yamashita S, Mimori K, et al:
MicroRNA-10b is a prognostic indicator in colorectal cancer and
confers resistance to the chemotherapeutic agent 5-fluorouracil in
colorectal cancer cells. Ann Surg Oncol. 19:3065–3071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu YC, Chen YJ, Wang HM, et al: Oncogenic
function and early detection potential of miRNA-10b in oral cancer
as identified by microRNA profiling. Cancer Prev Res. 5:665–674.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shields JM, Christy RJ and Yang VW:
Identification and characterization of a gene encoding a
gut-enriched Krüppel-like factor expressed during growth arrest. J
Biol Chem. 271:20009–20017. 1996.PubMed/NCBI
|
|
31
|
Garrett-Sinha LA, Eberspaecher H, Seldin
MF and de Crombrugghe B: A gene for a novel zinc-finger protein
expressed in differentiated epithelial cells and transiently in
certain mesenchymal cells. J Biol Chem. 271:31384–31390. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Segre JA, Bauer C and Fuchs E: Klf4 is a
transcription factor required for establishing the barrier function
of the skin. Nat Genet. 22:356–360. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ghaleb AM, McConnell BB, Nandan MO, Katz
JP, Kaestner KH and Yang VW: Haploinsufficiency of Krüppel-like
factor 4 promotes adenomatous polyposis coli dependent intestinal
tumorigenesis. Cancer Res. 67:7147–7154. 2007.
|
|
34
|
Jiang J, Chan YS, Loh YH, et al: A core
Klf circuitry regulates self-renewal of embryonic stem cells. Nat
Cell Biol. 10:353–360. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei D, Gong W, Kanai M, et al: Drastic
down-regulation of Krüppel-like factor 4 expression is critical in
human gastric cancer development and progression. Cancer Res.
65:2746–2754. 2005.PubMed/NCBI
|
|
36
|
Zhao W, Hisamuddin IM, Nandan MO, Babbin
BA, Lamb NE and Yang VW: Identification of Krüppel-like factor
4 as a potential tumor suppressor gene in colorectal cancer.
Oncogene. 23:395–402. 2004.
|
|
37
|
Wei D, Kanai M, Jia Z, Le X and Xie K:
Krüppel-like factor 4 induces p27Kip1
expression in and suppresses the growth and metastasis of human
pancreatic cancer cells. Cancer Res. 68:4631–4639. 2008.
|
|
38
|
Yang Y, Goldstein BG, Chao HH and Katz JP:
KLF4 and KLF5 regulate proliferation, apoptosis and invasion in
esophageal cancer cells. Cancer Biol Ther. 4:1216–1221. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu W, Hofstetter WL, Li H, et al: Putative
tumor-suppressive function of Krüppel-like factor 4 in primary lung
carcinoma. Clin Cancer Res. 15:5688–5695. 2009.
|
|
40
|
Wang J, Place RF, Huang V, et al:
Prognostic value and function of KLF4 in prostate cancer: RNAa and
vector-mediated overexpression identify KLF4 as an inhibitor of
tumor cell growth and migration. Cancer Res. 70:10182–10191. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kanai M, Wei D, Li Q, et al: Loss of
Krüppel-like factor 4 expression contributes to Sp1 overexpression
and human gastric cancer development and progression. Clin Cancer
Res. 12:6395–6402. 2006.
|
|
42
|
Li Q, Gao Y, Jia Z, et al: Dysregulated
Krüppel-like factor 4 and vitamin D receptor signaling contribute
to progression of hepatocellular carcinoma. Gastroenterology.
143:799–810. 2012.
|
|
43
|
Fidler IJ: The pathogenesis of cancer
metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003.
|
|
44
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ibrahim SA, Yip GW, Stock C, et al:
Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer
cell motility and invasiveness via a Rho-GTPase- and
E-cadherin-dependent mechanism. Int J Cancer. 131:E884–E896. 2012.
View Article : Google Scholar : PubMed/NCBI
|
